Advertisement
Advertisement
LUNG
Pulmonx Corporation Common Stock
2.80
USDSponsored
0.00
0.00%
Nov 10, 15:59 UTC -5
Closed
After-Market
2.79
-0.01
-0.54%
Pulmonx Corporation Common Stock (LUNG) Earnings
LUNG Earnings Reports
Positive Surprise Ratio
LUNG beat 24 of 25 last estimates.
96%
Next Report
Date of Next Report
Mar 02, 2027
Estimate for Q4 26 (Revenue/ EPS)
$25.34M
/-$0.22
Implied change from Q3 26 (Revenue/ EPS)
+10.96%
/+15.79%
Implied change from Q4 25 (Revenue/ EPS)
+12.12%
/-12.00%
Pulmonx Corporation Common Stock earnings per share and revenue
On Oct 27, 2026, LUNG reported earnings of -0.19 USD per share (EPS) for Q3 26, beating the estimate of -0.26 USD, resulting in a 27.40% surprise. Revenue reached 22.84 million, compared to an expected 22.38 million, with a 2.02% difference. The market reacted with a +27.27% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.22 USD, with revenue projected to reach 25.34 million USD, implying an increase of 15.79% EPS, and increase of 10.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Azenta, Inc.
Report Date
Nov 10, 2026 For Q4 26
Estimate
$0.11
Actual
$0.28
Surprise
+153.62%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Carlsmed, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.40
Actual
-$0.34
Surprise
+16.79%
Claritev Corporation
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$3.69
Actual
-$3.64
Surprise
+1.60%
Senseonics Holdings, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.50
Surprise
+5.05%
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.01
Actual
$0.00
Surprise
+100.00%
CareCloud, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.11
Actual
$0.14
Surprise
+19.35%
Neuraxis, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.52
Surprise
-49.94%
Hims & Hers Health, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.06
Actual
$0.03
Surprise
-53.78%
FAQ
What were Pulmonx Corporation Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Pulmonx Corporation Common Stock reported EPS of -$0.19, beating estimates by 27.4%, and revenue of $22.84M, 2.02% above expectations.
How did the market react to Pulmonx Corporation Common Stock's Q3 2026 earnings?
The stock price moved up 27.27%, changed from $1.98 before the earnings release to $2.52 the day after.
When is Pulmonx Corporation Common Stock expected to report next?
The next earning report is scheduled for Mar 02, 2027.
What are the forecasts for Pulmonx Corporation Common Stock's next earnings report?
Based on --
analysts, Pulmonx Corporation Common Stock is expected to report EPS of -$0.22 and revenue of $25.34M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.